LOX-1, a new marker of risk and prognosis in coronary artery disease?

Molecular and Cellular Biochemistry

Volumn 383, Issue 1-2, 2013, Pages 223-230

  Lubrano, Valter ^a   Balzan, Silvana ^b  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; IL 6; Inflammation; LOX 1; Ox LDL; Receptors

Indexed keywords

INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

CORONARY ARTERY DISEASE; DISEASE MARKER; GENE EXPRESSION; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; LIPID PEROXIDATION; PROGNOSIS; RECEPTORS, LDL; RISK FACTORS;

EID: 84885422320     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1770-z     Document Type: Review

References (60)

1. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340(2):115-126
2. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H (2003) Role of oxidative stress in atherosclerosis. Am J Cardiol 91(3A):7A-11A
3. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241. doi: 10.1038/35025203
4. Pluddemann A, Neyen C, Gordon S (2007) Macrophage scavenger receptors and host-derived ligands. Methods 43(3):207-217
5. Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, Liu S, Mehta JL (2012) Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 14:150-159
6. Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, Kita T (2000) Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol 20(3):715-720
7. Inoue N, Sawamura T (2007) Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases. Methods 43(3):218-222
8. Zhang L, Zhou G, Song W, Tan X, Guo Y, Zhou B, Jing H, Zhao S, Chen L (2012) Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo. Apoptosis 17(1):25-36. doi: 10.1007/s10495-011-0653-6
9. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386(6620):73-77
10. Li DY, Mehta JL (2000) Antisense to LOX-1 inhibits ox-LDL-mediated upregulation of MCP-1 expression and monocyte adhesion to human coronary artery endothelial cells. Circulation 101:2889-2895
11. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O (1998) Identification of the lectin-like receptor for oxidized lowdensity lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334:9-13
12. Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T, Sawamura T (2001) Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 282(1):153-158
13. Iwai-Kanai E, Hasegawa K, Sawamura T, Iwai-Kanai E, Hasegawa K, Sawamura T (2001) Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation 104(24):2948-2954
14. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T (1998) Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83(3):328-333
15. Mehta JL, Li DY (1998) Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 248(3):511-514
16. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S (2002) Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 511(1-3):170-174
17. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL (1999) Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 84(9):1043-1049
18. Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T (1997) Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 237(3):496-498
19. Chen M, Kakutani M, Minami M, Kataoka H, Kume N, Narumiya S, Kita T, Masaki T, Sawamura T (2000) Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 20(4):1107-1115
20. Kataoka H, Kume N, Miyamoto S, Minami, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T (1999) Expression of lectin like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99(24):3110-3117
21. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio V, Sawamura T (2001) The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276:13750-13755
22. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275(17):12633-12638
23. Mehta JL, Li DY, Chen HJI, Joseph J, Romeo F (2001) Inhibition of LOX-1 by statins may relate to upregulation of eNOS. Biochem Biophys Res Commun 289:857-861
24. Gierens H, Nauck M, Roth M, Schinker R, Schürmann C, Scharnagl H, Neuhaus G, Wieland H, März W (2000) Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 20:1777-1783
25. Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4(Suppl 3):S233-S242
26. Rosenson RS (1993) Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 22(3):933-940
27. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen MR (1988) Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37(9):859-865
28. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (2006) Lectin-like, oxidized low-density lipopro tein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69:36
29. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2005) Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182(1):1-15
30. Park H, Adsit FG, Boyington JC (2005) The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. J Biol Chem 280:13593
31. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL (2011) Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 342(2):135-142
32. Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, Masaki T (1999) Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 39:177-184
33. Shi X, Niimi S, Ohtani T, Machida S (2001) Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci 114(Pt 7):1273-1282
34. Mehta JL, Li D (2002) Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 39(9):1429-1435
35. Li D, Williams V, Liu L, Chen H, Sawamura T, Antakli T, Mehta JL (2002) LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol 283:H1795-H1801
36. Vecchione L, Gargiul E, Borgiani P, Predazzi I, Mango R, Romeo F, Magnani M, Novelli G (2007) Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2:147-151
37. Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R, Pignatti PF (2006) On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 14(1):127-130
38. Cheng Y, Wei Y, Li W, Chen J, Zhang W, Hui R, Zhang Z, Dang A (2011) Associations between oxidized-lipoprotein receptor 1 G501C and 3′-UTR-C188T polymorphisms and coronary artery disease: a meta-analysis. Cardiology 119(2):90-95
39. Mango R, Clementi F, Borgiani P et al (2003) Association of single nucleotide polymorphisms in the oxidized LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 40:933-936
40. Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G (2008) The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J Mol Cell Cardiol 44(3):561-570
41. Chen Q, Reis SE, Kammerer C et al (2003) Genetic variation in lectin-like oxidized low-density lipoprotein receptor1 (LOX1) gene and the risk of coronary artery disease. Circulation 107:3146-3151
42. Kurnaz O, Akadam-Teker AB, Yilmaz-Aydoǧan H et al (2012) The LOX-1 3′UTR188CT polymorphism and coronary artery disease in Turkish patients. Mol Biol Rep 39(4):4351-4358
43. Biocca S, Falconi M, Filesi I et al (2009) Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS ONE 4(2):e4648
44. Keidar S, Kaplan M, Hoffman A et al (1995) Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 115(2):201-215
45. Li DY, Zhang YC, Philips MI et al (1999) Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 84(9):1043-1049
46. Wang X, Phillips MI, Mehta JL (2011) LOX-1 and angiotensin receptors, and their interplay. Cardiovasc Drugs Ther 25(5):401-417
47. Lubrano V, Del Turco S, Nicolini G, Di Cecco P, Basta G (2008) Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers. Lipids 43(10):945-950
48. Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M, Yanagida K, Kakino A, Iwamoto S, Watanabe M, Ogura S, Otsui K, Matsuda H, Uchida K, Yoshimoto R, Sawamura T (2010) LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem 56(4):550-558
49. Kataoka K, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Iwai-Kanai E, Kawamura T, Hirai T, Kita T, Nohara R (2003) LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 300:656-660
50. Hu C, Dandapat A, Chen J, Fujita Y, Inoue N, Kawase Y, Jishage K, Suzuki H, Sawamura T, Mehta JL (2007) LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. Cardiovasc Res 76:292-302
51. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T (2010) Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome-a pilot study. Circ J 74(7):1399-1404
52. Kamezaki F, Yamashita K, Tasaki H, Kume N, Mitsuoka H, Kita T, Adachi T, Otsuji Y (2009) Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease. Int J Cardiol 134(2):285-287
53. Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, Tanaka M, Ueda A, Kominami G, Kambara H, Kimura T, Kita T (2005) Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 112(6):812-818
54. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T (2010) Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome-comparison with other biomarkers. J Cardiol 56(2):159-165
55. Li DY, Chen HJ, Mehta JL (2001) Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of ox-LDL and reduction in PKB phosphorylation. Cardiovasc Res 52:217-225
56. Toba H, Shimizu T, Miki S, Inoue R, Yoshimura A, Tsukamoto R, Sawai N, Kobara M, Nakata T (2006) Calcium channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized lowdensity lipoprotein receptor-1 expression in endothelial cells. Hypertens Res 29:105-116
57. Mehta JL, Chen J, Yu F, Li DY (2004) Aspirin inhibits OX-LDL-mediated LOX-1 expression and metalloproteinase-1 in human corouary eudothelid cells. Cardiovasc Res 64:243-249
58. Wang TJ (2011) Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction. Circulation 123:551-565
59. Mango R, Biocca S, del Vecchio F (2005) In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 97(2):152-158
60. Kobayashi N, Hata N, Kume N et al (2013) Detection of acute aortic dissection by extremely high soluble lectin-like oxidized LDL receptor-1 (sLOX-1) and low troponin T levels in blood. Int J Cardiol 165(3):557-559